Condition
Revision Arthroplasty
Total Trials
5
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 85/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
1 of 0 completed with results
Key Signals
1 with results0
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Enrolling By Invitation2
Withdrawn2
Terminated1
Clinical Trials (5)
Showing 5 of 5 trials
NCT06699160WithdrawnPrimary
Refobacin Revision-3 Bone Cement Post-Market Study
NCT07053943Enrolling By Invitation
Infection-related Revision Rates After Single-dose Versus Multiple-dose Antibiotic Prophylaxis in Primary Hip and Knee Arthroplasty: a Comparative Implementation Study.
NCT06203756Not ApplicableEnrolling By Invitation
Patient Outcomes With Robotic-Assisted Total Knee Arthroplasty
NCT05357664Not ApplicableTerminated
PINNACLE® DM RSA Study
NCT00858598Withdrawn
Pro Osteon Bone Void Filler Study
Showing all 5 trials